English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 10 Help

Selected(0)Clear Items/Page:    Sort:
Characteristics of clinical trials of new oncology drugs approved in China Journal article
Yang, Jing, Yang, Ji, Hu, Yuan Jia. Characteristics of clinical trials of new oncology drugs approved in China[J]. Cancer, 2024, 130(5), 671-682.
Authors:  Yang, Jing;  Yang, Ji;  Hu, Yuan Jia
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:6.1/6.7 | Submit date：2024/05/16
Clinical Evidence  Drug Lag  Novel Anticancer Drugs  Pivotal Clinical Trials  Programmed Death-1 (Pd-1) Inhibitors  Programmed Death-ligand 1 (Pd-l1) Inhibitors  
Characteristics of clinical trials of new oncology drugs approved in China Review article
2023
Authors:  Jing Yang;  Ji Yang;  HU YUANJIA
Adobe PDF | Favorite | TC[WOS]:2 TC[Scopus]:2  IF:6.1/6.7 | Submit date：2024/01/02
Clinical Evidence  Drug Lag  Novel Anticancer Drugs  Pivotal Clinical Trials  Programmed Death-1 (Pd-1) Inhibitors  Programmed Death-ligand 1 (Pd-l1) Inhibitors  
Myricetin inhibits interferon-γ-induced PD-L1 and IDO1 expression in lung cancer cells Journal article
Chen, Yu Chi, He, Xin Ling, Qi, Lu, Shi, Wei, Yuan, Luo Wei, Huang, Mu Yang, Xu, Yu Lian, Chen, Xiuping, Gu, Lei, Zhang, Le Le, Lu, Jin Jian. Myricetin inhibits interferon-γ-induced PD-L1 and IDO1 expression in lung cancer cells[J]. Biochemical Pharmacology, 2022, 197, 114940.
Authors:  Chen, Yu Chi;  He, Xin Ling;  Qi, Lu;  Shi, Wei;  Yuan, Luo Wei; et al.
Favorite | TC[WOS]:21 TC[Scopus]:24  IF:5.3/5.2 | Submit date：2022/03/28
Indoleamine 2, 3-dioxygenase 1  Interferon-γ  Lung Cancer  Myricetin  Programmed Death Ligand-1  
Aptamer-functionalized Ti3C2-MXene Nanosheets with One-step Potentiometric Detection of Programmed Death-ligand 1 Journal article
Li, Bin, Pu, Wenyuan, Weng, Lingyan, Lyu, Peng, Xu, Houxi, Zhang, Wen, Ge, Lilin, Kwok, Hang Fai, Wu, Qinan. Aptamer-functionalized Ti3C2-MXene Nanosheets with One-step Potentiometric Detection of Programmed Death-ligand 1[J]. Electroanalysis, 2021, 34(1), 2-7.
Authors:  Li, Bin;  Pu, Wenyuan;  Weng, Lingyan;  Lyu, Peng;  Xu, Houxi; et al.
Favorite | TC[WOS]:6 TC[Scopus]:6  IF:2.7/2.7 | Submit date：2022/02/21
Potentiometric Aptasensor  Ti3c2-mxene Nanosheets  Programmed Death-ligand 1  Electric Potential  Surface Modified Electrode  
Nagilactone E increases PD-L1 expression through activation of c-Jun in lung cancer cells Journal article
CHEN,Yu Chi, HUANG,Mu Yang, ZHANG,Le Le, FENG,Zhe Ling, JIANG,Xiao Ming, YUAN,Luo Wei, HUANG,Run Yue, LIU,Bo, YU,Hua, WANG,Yi Tao, CHEN,Xiu Ping, LIN,Li Gen, LU,Jin Jian. Nagilactone E increases PD-L1 expression through activation of c-Jun in lung cancer cells[J]. Chinese Journal of Natural Medicines, 2020, 18(7), 517-525.
Authors:  CHEN,Yu Chi;  HUANG,Mu Yang;  ZHANG,Le Le;  FENG,Zhe Ling;  JIANG,Xiao Ming; et al.
Favorite | TC[WOS]:15 TC[Scopus]:15  IF:4.0/3.7 | Submit date：2021/03/01
Programmed Death Ligand 1  Nagilactone e  Lung Cancer  C-jun  Jnk  
Platycodin D triggers the extracellular release of programed death Ligand-1 in lung cancer cells Journal article
Mu-Yang Huang, Xiao-Ming Jiang, Yu-Lian Xu, Luo-Wei Yuan, Yu-Chi Chen, Guozhen Cui, Run-Yue Huang, Bo Liu, Yitao Wang, Xiuping Chen, Jin-Jian Lu. Platycodin D triggers the extracellular release of programed death Ligand-1 in lung cancer cells[J]. FOOD AND CHEMICAL TOXICOLOGY, 2019, 131.
Authors:  Mu-Yang Huang;  Xiao-Ming Jiang;  Yu-Lian Xu;  Luo-Wei Yuan;  Yu-Chi Chen; et al.
Favorite | TC[WOS]:52 TC[Scopus]:50  IF:3.9/4.5 | Submit date：2019/11/22
Programmed Death Ligand-1  Platycodin d  Extracellular Release  Natural Products  Cancer  
Targeting PD-L1 Protein: Translation, Modification and Transport Journal article
Wei R., Guo L., Wang Q., Miao J., Kwok H.F., Lin Y.. Targeting PD-L1 Protein: Translation, Modification and Transport[J]. Current protein & peptide science, 2019, 20(1), 82-91.
Authors:  Wei R.;  Guo L.;  Wang Q.;  Miao J.;  Kwok H.F.; et al.
Favorite | TC[WOS]:22 TC[Scopus]:22  IF:1.9/3.0 | Submit date：2018/12/19
Immunotherapy  Modification  Programmed Cell Death Protein 1 (Pd-1)  Programmed Death Ligand 1 (Pd-l1)  Translation  Transport.  
The Roles of microRNAs in Regulating the Expression of PD-1/PD-L1 Immune Checkpoint Journal article
Wang, Qingshui, Lin, Wei, Tang, Xiaoqiong, Li, Suhuan, Guo, Libin, Lin, Yao, Kwok, Hang Fai. The Roles of microRNAs in Regulating the Expression of PD-1/PD-L1 Immune Checkpoint[J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18(12).
Authors:  Wang, Qingshui;  Lin, Wei;  Tang, Xiaoqiong;  Li, Suhuan;  Guo, Libin; et al.
Favorite | TC[WOS]:95 TC[Scopus]:95 | Submit date：2018/10/30
Programmed Death-ligand 1 (Pd-l1)  Programmed Death 1(Pd-1)  Micrornas  Immune Checkpoint  
The roles of microRNAs in regulating the expression of PD-1/PD-l1 immune checkpoint Journal article
Wang,Qingshui, Lin,Wei, Tang,Xiaoqiong, Li,Suhuan, Guo,Libin, Lin,Yao, Kwok,Hang Fai. The roles of microRNAs in regulating the expression of PD-1/PD-l1 immune checkpoint[J]. International Journal of Molecular Sciences, 2017, 18(12).
Authors:  Wang,Qingshui;  Lin,Wei;  Tang,Xiaoqiong;  Li,Suhuan;  Guo,Libin; et al.
Favorite | TC[WOS]:95 TC[Scopus]:95  IF:4.9/5.6 | Submit date：2021/03/04
Immune Checkpoint  Micrornas  Programmed Death 1(Pd-1)  Programmed Death-ligand 1 (Pd-l1)  
The prognostic significance of PD-L1 in bladder cancer Journal article
Huang Y., Zhang S.-D., McCrudden C., Chan K.-W., Lin Y., Kwok H.-F.. The prognostic significance of PD-L1 in bladder cancer[J]. Oncology Reports, 2015, 33(6), 3075.
Authors:  Huang Y.;  Zhang S.-D.;  McCrudden C.;  Chan K.-W.;  Lin Y.; et al.
Favorite | TC[WOS]:87 TC[Scopus]:94 | Submit date：2018/10/30
Bladder Cancer  Patient Survival  Prognostic Marker  Programmed Death Ligand-1  Therapeutic Targets